Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trials

Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trials

Abstract Background Previous studies suggested that phosphodiesterase 5 inhibitors (PDE5i) have a beneficial effect in patients with heart failure (HF), although the results were inconsistent. We performed a meta-analysis to evaluate the effect of PDE5i in HF patients, and investigated the relations...

Full description

Bibliographic Details
Main Authors: In-Chang Hwang, Yong-Jin Kim, Jun-Bean Park, Yeonyee E. Yoon, Seung-Pyo Lee, Hyung-Kwan Kim, Goo-Yeong Cho, Dae-Won Sohn
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Cardiovascular Disorders
Subjects:
Phosphodiesterase 5 inhibitor
Heart failure
Pulmonary hypertension
Randomized controlled trial
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12872-017-0576-4

Internet

http://link.springer.com/article/10.1186/s12872-017-0576-4

Similar Items